ALNY in the 13F filings
Alnylam Pharmaceuticals Inc · CUSIP 02043Q107
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 22 Jan 2026
- Managers listing it
- 35
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 26 listed it in both
- Shares listed
- 59,125,355
- combined, among listed positions
- Reported value
- $23.5bn
- combined, at the quarter end
Among the 92 comparable managers: 15 buyers (opened or added shares) and 28 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +348,561.
Managers listing ALNY in Q4 2025
35 of 35 holders
Largest increases and reductions, by shares
Increases
- Invesco Ltdexisting position · 5,133,983 shares now+3,652,141
- D. E. Shaw & Co.existing position · 444,493 shares now+245,076
- Two Sigma Advisers LPexisting position · 1,132,560 shares now+240,060
- Squarepoint Ops LLCexisting position · 350,969 shares now+205,404
- AQR Capital Management LLCexisting position · 919,959 shares now+175,951
Reductions
- Fidelity (FMR LLC)existing position · 15,902,149 shares now-865,476
- Jane Street Group LLCexisting position · 311,288 shares now-647,462
- Millennium Management LLCexisting position · 75,430 shares now-474,501
- Capital Research Global Investorsexisting position · 6,779,708 shares now-443,132
- Susquehanna International Group LLPexisting position · 191,820 shares now-385,812
New positions and exits
New (0)
No new position among listed positions.
Exited (8)
- ExodusPoint Capital Management LPwas $14m
- Holocene Advisors LPwas $6.0m
- Winton Group Ltdwas $3.1m
- Point72 Asset Management LPwas $2.8m
- Soros Fund Management LLCwas $2.0m
- Moore Capital Management LPwas $1.9m
- Freestone Grove Partners LPwas $644k
- Polen Capital Management LLCwas $316k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 4 | $407m | n.a. | n.a. |
| Q3 2013 | 6 | $1.2bn | n.a. | n.a. |
| Q4 2013 | 7 | $1.5bn | n.a. | n.a. |
| Q1 2014 | 8 | $1.6bn | n.a. | n.a. |
| Q2 2014 | 6 | $1.7bn | n.a. | n.a. |
| Q3 2014 | 7 | $2.1bn | n.a. | n.a. |
| Q4 2014 | 6 | $2.2bn | n.a. | n.a. |
| Q1 2015 | 8 | $2.9bn | n.a. | n.a. |
| Q2 2015 | 6 | $3.3bn | n.a. | n.a. |
| Q3 2015 | 5 | $2.1bn | n.a. | n.a. |
| Q4 2015 | 6 | $2.7bn | n.a. | n.a. |
| Q1 2016 | 8 | $2.0bn | n.a. | n.a. |
| Q2 2016 | 7 | $2.0bn | n.a. | n.a. |
| Q3 2016 | 8 | $2.6bn | n.a. | n.a. |
| Q4 2016 | 8 | $1.6bn | n.a. | n.a. |
| Q1 2017 | 9 | $2.2bn | n.a. | n.a. |
| Q2 2017 | 14 | $3.8bn | n.a. | n.a. |
| Q3 2017 | 15 | $5.7bn | n.a. | n.a. |
| Q4 2017 | 14 | $6.3bn | n.a. | n.a. |
| Q1 2018 | 15 | $5.7bn | n.a. | n.a. |
| Q2 2018 | 15 | $4.4bn | n.a. | n.a. |
| Q3 2018 | 14 | $3.9bn | n.a. | n.a. |
| Q4 2018 | 10 | $3.3bn | n.a. | n.a. |
| Q1 2019 | 11 | $4.6bn | n.a. | n.a. |
| Q2 2019 | 16 | $3.8bn | n.a. | n.a. |
| Q3 2019 | 11 | $4.4bn | n.a. | n.a. |
| Q4 2019 | 13 | $6.2bn | n.a. | n.a. |
| Q1 2020 | 12 | $5.7bn | n.a. | n.a. |
| Q2 2020 | 15 | $7.7bn | n.a. | n.a. |
| Q3 2020 | 13 | $7.6bn | n.a. | n.a. |
| Q4 2020 | 13 | $6.5bn | n.a. | n.a. |
| Q1 2021 | 14 | $7.2bn | n.a. | n.a. |
| Q2 2021 | 13 | $8.8bn | n.a. | n.a. |
| Q3 2021 | 14 | $9.7bn | n.a. | n.a. |
| Q4 2021 | 12 | $8.8bn | n.a. | n.a. |
| Q1 2022 | 12 | $8.9bn | n.a. | n.a. |
| Q2 2022 | 13 | $8.1bn | n.a. | n.a. |
| Q3 2022 | 17 | $10.8bn | n.a. | n.a. |
| Q4 2022 | 16 | $13.7bn | n.a. | n.a. |
| Q1 2023 | 19 | $11.5bn | n.a. | n.a. |
| Q2 2023 | 16 | $10.6bn | n.a. | n.a. |
| Q3 2023 | 17 | $9.7bn | n.a. | n.a. |
| Q4 2023 | 15 | $10.0bn | 5 | 9 |
| Q1 2024 | 15 | $7.3bn | 10 | 6 |
| Q2 2024 | 19 | $12.5bn | 12 | 8 |
| Q3 2024 | 18 | $15.1bn | 7 | 11 |
| Q4 2024 | 15 | $12.8bn | 8 | 7 |
| Q1 2025 | 18 | $14.9bn | 11 | 7 |
| Q2 2025 | 22 | $18.3bn | 13 | 10 |
| Q3 2025 | 33 | $26.6bn | 25 | 8 |
| Q4 2025 | 24 | $23.4bn | 15 | 28 |
| Q1 2026 | 22 | $17.9bn | 16 | 18 |
| Q2 2026 | 21 | $15.9bn | 17 | 18 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ALNY and LLY →ALNY and JNJ →ALNY and VRTX →Choose a stock to compare with ALNY →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ALNY, latest filings →Back to the 13F Explorer →